Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 562

1.

TACI, unlike BAFF-R, is solely activated by oligomeric BAFF and APRIL to support survival of activated B cells and plasmablasts.

Bossen C, Cachero TG, Tardivel A, Ingold K, Willen L, Dobles M, Scott ML, Maquelin A, Belnoue E, Siegrist CA, Chevrier S, Acha-Orbea H, Leung H, Mackay F, Tschopp J, Schneider P.

Blood. 2008 Feb 1;111(3):1004-12. Epub 2007 Oct 17.

2.

Deficient TACI expression on B lymphocytes of newborn mice leads to defective Ig secretion in response to BAFF or APRIL.

Kanswal S, Katsenelson N, Selvapandiyan A, Bram RJ, Akkoyunlu M.

J Immunol. 2008 Jul 15;181(2):976-90. Erratum in: J Immunol. 2008 Oct 1;181(7):5174.

3.

Synthetic CpG oligodeoxynucleotides augment BAFF- and APRIL-mediated immunoglobulin secretion.

Katsenelson N, Kanswal S, Puig M, Mostowski H, Verthelyi D, Akkoyunlu M.

Eur J Immunol. 2007 Jul;37(7):1785-95.

4.

TACI, an enigmatic BAFF/APRIL receptor, with new unappreciated biochemical and biological properties.

Mackay F, Schneider P.

Cytokine Growth Factor Rev. 2008 Jun-Aug;19(3-4):263-76. doi: 10.1016/j.cytogfr.2008.04.006. Epub 2008 Jun 2. Review.

PMID:
18514565
5.

BAFF, APRIL and their receptors: structure, function and signaling.

Bossen C, Schneider P.

Semin Immunol. 2006 Oct;18(5):263-75. Epub 2006 Aug 17. Review.

PMID:
16914324
6.

Selectivity of BAFF/BLyS and APRIL for binding to the TNF family receptors BAFFR/BR3 and BCMA.

Day ES, Cachero TG, Qian F, Sun Y, Wen D, Pelletier M, Hsu YM, Whitty A.

Biochemistry. 2005 Feb 15;44(6):1919-31.

PMID:
15697217
7.

Identification of proteoglycans as the APRIL-specific binding partners.

Ingold K, Zumsteg A, Tardivel A, Huard B, Steiner QG, Cachero TG, Qiang F, Gorelik L, Kalled SL, Acha-Orbea H, Rennert PD, Tschopp J, Schneider P.

J Exp Med. 2005 May 2;201(9):1375-83. Epub 2005 Apr 25.

8.

Hodgkin lymphoma cells express TACI and BCMA receptors and generate survival and proliferation signals in response to BAFF and APRIL.

Chiu A, Xu W, He B, Dillon SR, Gross JA, Sievers E, Qiao X, Santini P, Hyjek E, Lee JW, Cesarman E, Chadburn A, Knowles DM, Cerutti A.

Blood. 2007 Jan 15;109(2):729-39. Epub 2006 Sep 7.

9.

APRIL is overexpressed in cancer: link with tumor progression.

Moreaux J, Veyrune JL, De Vos J, Klein B.

BMC Cancer. 2009 Mar 16;9:83. doi: 10.1186/1471-2407-9-83.

10.

APRIL and TACI interact with syndecan-1 on the surface of multiple myeloma cells to form an essential survival loop.

Moreaux J, Sprynski AC, Dillon SR, Mahtouk K, Jourdan M, Ythier A, Moine P, Robert N, Jourdan E, Rossi JF, Klein B.

Eur J Haematol. 2009 Aug;83(2):119-29. doi: 10.1111/j.1600-0609.2009.01262.x. Epub 2009 May 30.

PMID:
19456850
11.

TACI and BAFF-R mediate isotype switching in B cells.

Castigli E, Wilson SA, Scott S, Dedeoglu F, Xu S, Lam KP, Bram RJ, Jabara H, Geha RS.

J Exp Med. 2005 Jan 3;201(1):35-9.

12.

In vitro and in vivo activation induces BAFF and APRIL expression in B cells.

Chu VT, Enghard P, Riemekasten G, Berek C.

J Immunol. 2007 Nov 1;179(9):5947-57.

13.

B cell-activating factor belonging to the TNF family acts through separate receptors to support B cell survival and T cell-independent antibody formation.

Shulga-Morskaya S, Dobles M, Walsh ME, Ng LG, MacKay F, Rao SP, Kalled SL, Scott ML.

J Immunol. 2004 Aug 15;173(4):2331-41.

14.

APRIL and BAFF proteins increase proliferation of human adipose-derived stem cells through activation of Erk1/2 MAP kinase.

Zonca M, Mancheño-Corvo P, DelaRosa O, Mañes S, Büscher D, Lombardo E, Planelles L.

Tissue Eng Part A. 2012 Apr;18(7-8):852-9. doi: 10.1089/ten.TEA.2011.0316. Epub 2011 Dec 22.

PMID:
22059379
15.
16.

No evidence that soluble TACI induces signalling via membrane-expressed BAFF and APRIL in myeloid cells.

Nys J, Smulski CR, Tardivel A, Willen L, Kowalczyk C, Donzé O, Huard B, Hess H, Schneider P.

PLoS One. 2013 Apr 19;8(4):e61350. doi: 10.1371/journal.pone.0061350. Print 2013.

17.

Expressions of BAFF/BAFF receptors and their correlation with disease activity in Chinese SLE patients.

Zhao LD, Li Y, Smith MF Jr, Wang JS, Zhang W, Tang FL, Tian XP, Wang HY, Zhang FC, Ba DN, He W, Zhang X.

Lupus. 2010 Nov;19(13):1534-49. doi: 10.1177/0961203310375268.

PMID:
20974656
18.

Stoichiometry of Heteromeric BAFF and APRIL Cytokines Dictates Their Receptor Binding and Signaling Properties.

Schuepbach-Mallepell S, Das D, Willen L, Vigolo M, Tardivel A, Lebon L, Kowalczyk-Quintas C, Nys J, Smulski C, Zheng TS, Maskos K, Lammens A, Jiang X, Hess H, Tan SL, Schneider P.

J Biol Chem. 2015 Jun 26;290(26):16330-42. doi: 10.1074/jbc.M115.661405. Epub 2015 May 7.

19.

Adipocytes as immune cells: differential expression of TWEAK, BAFF, and APRIL and their receptors (Fn14, BAFF-R, TACI, and BCMA) at different stages of normal and pathological adipose tissue development.

Alexaki VI, Notas G, Pelekanou V, Kampa M, Valkanou M, Theodoropoulos P, Stathopoulos EN, Tsapis A, Castanas E.

J Immunol. 2009 Nov 1;183(9):5948-56. doi: 10.4049/jimmunol.0901186. Epub 2009 Oct 14.

20.

TACI attenuates antibody production costimulated by BAFF-R and CD40.

Sakurai D, Kanno Y, Hase H, Kojima H, Okumura K, Kobata T.

Eur J Immunol. 2007 Jan;37(1):110-8.

Items per page

Supplemental Content

Write to the Help Desk